CHH-54219-57809
2 vaccinations
6 coded responses
17 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 191 / PA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Photophobia — Feeling: Fair · Site: Pain, Redness, Swelling · HeadacheFree text: Lightheadedness, some light sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2020-12-24
Survey response — day 7, dose 1MedDRA: Adverse reaction — Feeling: Fair · Site: Itching · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Symptoms are between mild and moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-24
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Back pain, Joint swelling, Muscle fatigue, Muscular weakness, Musculoskeletal pain, Pain in extremity, Peripheral swelling — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Extreme muscle fatigue, weakness and pain in all limbs, buttocks and upper back; swollen right knee and thigh. I did not receive my daily check-in since 12.20.2020. Was not able to check in v-safe indepently from v-safe reminder.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-07
Survey response — day 21, dose 1MedDRA: Asthenia, Back pain, Headache, Muscle fatigue, Neck pain, Pain in extremity — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Extreme muscle fatigue and tactile pain in all limbs and low back; barely ambulatory. Weakness in dominant arm and hand. Tactile Pain in torso neck and head. My PCP prescribed Gabapentin 100mg once daily, which has improved my symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-17
- 2021-01-19
-
2021-01-20
Survey response — day 7, dose 2MedDRA: Myalgia — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Muscle aches in hip, butt and upper backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-12
- 2021-02-17
- 2021-02-24
- 2021-04-17
- 2021-07-16
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Call center
4 call center cases
4 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Systemic reaction (other): Lightheadedness, some light sensitivity
Release 1 — day 7, dose 1
Systemic reaction (other): Symptoms are between mild and moderate
Release 1 — day 14, dose 1
Symptoms: Extreme muscle fatigue, weakness and pain in all limbs, buttocks and upper back; swollen right knee and thigh. I did not receive my daily check-in since 12.20.2020. Was not able to check in v-safe indepently from v-safe reminder.
Release 1 — day 21, dose 1
Symptoms: Extreme muscle fatigue and tactile pain in all limbs and low back; barely ambulatory. Weakness in dominant arm and hand. Tactile Pain in torso neck and head. My PCP prescribed Gabapentin 100mg once daily, which has improved my symptoms.
Release 2 — day 7, dose 2
Systemic reaction (other): Muscle aches in hip, butt and upper back
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Muscle fatigue | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Musculoskeletal pain | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release